SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 69 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $451,467 | +48.2% | 63,588 | +57.4% | 0.00% | – |
| Q2 2023 | $304,540 | -19.6% | 40,390 | +37.4% | 0.00% | – |
| Q1 2022 | $379,000 | -44.5% | 29,405 | +7.0% | 0.00% | -100.0% |
| Q4 2021 | $683,000 | -27.0% | 27,487 | -3.0% | 0.00% | 0.0% |
| Q3 2021 | $936,000 | +19.5% | 28,351 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $783,000 | -39.6% | 27,108 | +5.9% | 0.00% | -50.0% |
| Q1 2021 | $1,297,000 | -1.7% | 25,605 | -5.8% | 0.00% | 0.0% |
| Q4 2020 | $1,319,000 | +232.2% | 27,174 | +21.1% | 0.00% | +100.0% |
| Q3 2020 | $397,000 | -17.3% | 22,436 | -14.9% | 0.00% | 0.0% |
| Q2 2020 | $480,000 | +92.0% | 26,371 | +27.9% | 0.00% | 0.0% |
| Q1 2020 | $250,000 | -6.0% | 20,626 | +2.1% | 0.00% | – |
| Q4 2019 | $266,000 | +52.0% | 20,201 | +3.3% | 0.00% | – |
| Q3 2019 | $175,000 | -42.4% | 19,553 | +2.0% | 0.00% | -100.0% |
| Q2 2019 | $304,000 | -3.2% | 19,163 | +14.5% | 0.00% | 0.0% |
| Q1 2019 | $314,000 | – | 16,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |